Antiviral drugs Market Size, Share, Trends and Forecast (2035)
The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis. Over the years, there has been a growing focus on the development of safe and effective novel antiviral drugs therapeutics owing to the rising cases of life-threatening viral diseases
The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:
A detailed assessment of the current market landscape of commercially available antiviral drugs.
A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).
A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).
A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Mechanism of Action
Fusion Inhibitors
DNA Polymerases
Protease Inhibitors
Reverse Transcriptase Inhibitors
Other Mechanisms
Target Indication
Human Immunodeficiency Virus Infection
Hepatitis
Herpes Simplex Virus Infection
Cytomegalovirus Infection\
Influenza
Coronavirus Infection
Other Target Indications
Type of Drug Target
Virus Targets
Host Targets
Type of Therapy
Monotherapy
Combination Therapy
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
MENA
Rest of the World
Key companies covered in the report
AbbVie
AstraZeneca
Bristol-Myers Squibb
Genentech
Gilead Sciences
GlaxoSmithKline (GSK)
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
ViiV Healthcare
For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
